Chronic Lymphatic Leukaemia

Chronic lymphocytic leukemia Dr .E.Thirulogachandar Prof .Dr.S.Tito’s unit

Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object]

Etiology & pathogenesis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Probablity of disease progression in trt.free interval

Clinical features : ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Laboratory investigations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Marrow findings ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object]

Journal of Clinical Oncology, Vol 27, No 11 (April 10), 2009: pp. 1844-1849 ,[object Object],[object Object]

Microvesicles in CLL: A New Form of Tumor and Stromal Cell Communication ,[object Object]

Differential diagnosis: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Indications for treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Treatment response ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Refractory CLL ,[object Object]

Journal of Clinical Oncology, Vol 27 , No 27 (September 20), 2009: pp. 4578-4584 ,[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Richter’s transformation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Prognosis ,[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Clinical features ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Laboratory diagnosis ,[object Object],[object Object],[object Object],[object Object],[object Object]

Cytochemistry & immunophenotype ,[object Object],[object Object],[object Object],[object Object]

Treatment indications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Treatment ,[object Object],[object Object],[object Object],[object Object]

References ,[object Object],[object Object],[object Object],[object Object]

Chronic Lymphatic Leukaemia

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (17)

Similar to Chronic Lymphatic Leukaemia

Similar to Chronic Lymphatic Leukaemia (20)

More from Stanley Medical College, Department of Medicine

More from Stanley Medical College, Department of Medicine (20)

Recently uploaded

Recently uploaded (20)

Chronic Lymphatic Leukaemia